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Summary
Objective: Cultures of primary articular chondrocytes for studying chondrocyte biology are notoriously difﬁcult to handle. One alternative is the
use of chondrocytic cell lines. Because the HCS-2/8 cells are the most widely used cell line in cartilage research, we investigated the
molecular phenotype of these cells by mRNA-expression proﬁling.
Design: Monolayers of HCS-2/8 cells were cultured to sub-conﬂuence, conﬂuence and over-conﬂuence; primary human chondrocytes were
grown in monolayer culture and alginate-bead cultures and several other chondrocytic cell lines were cultured as monolayers. RNA was
isolated and analyzed by cDNA array proﬁling using Affymetrix GeneChips (U95A/U95Av2) and quantitative PCR.
Results: Important similarities, but also remarkable differences between the HCS-2/8 cells and adult human articular chondrocytes were
detected: Aggrecan and several cartilage typical collagens as well as SOX9 transcripts were strongly expressed in HCS-2/8 cells, whereas
HCS-2/8 cells expressed hardly any chondrocyte-typical cartilage matrix degrading enzymes. Of all culturing conditions, clustering analysis
showed that HCS-2/8 cultured at conﬂuence are most closely related to primary chondrocytes.
Conclusion: Our study conﬁrms how careful one needs to be in choosing in vitro model systems for investigating effects of interest. The major
issue of chondrocyte cell lines appears to be that they mainly proliferate and show less expression of genes of matrix synthesis and turnover.
A successful approach will have to select suitable chondrocyte cell lines and to validate ﬁndings obtained using primary chondrocytes. This
allows to establish a reproducible in vitro model showing the property of interest and subsequently to relate back the obtained results to the
physiologic situation.
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Cultures of primary articular chondrocytes as in vitro model
systems for studying the cellular behavior of chondrocytes
as well as mechanisms of degenerative joint disease are
difﬁcult, because primary adult chondrocytes are in normal
articular cartilage largely post-mitotic1. Thus, also after
isolation of the cells from their natural protecting surround-
ings, chondrocytes in their native phenotype show hardly
any proliferation. If they start to do so, this is usually
accompanied by the loss of differentiation which involves
signiﬁcant changes in their molecular phenotype: classi-
cally, they stop to express cartilage collagen type II and
aggrecan and initiate strongly the expression of collagen
types I and III2e4. Together with the fact that human primary
chondrocytes are difﬁcult to obtain for all sorts of reasons
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Received 3 May 2004; revision accepted 11 August 2004.92including the difﬁculty to isolate from a single joint
a signiﬁcant number of cells, there exists a high need for
well available cellular systems in order to simulate and
investigate cellular reaction patterns in deﬁned conditions in
vitro. Another major problem in working with primary human
adult articular chondrocytes is the high variability of reaction
pattern in between different preparations obtained due to
a high inter-individual variability in between different donors.
The only way to circumvent these problems appears to be
the establishment of immortalized chondrocytic cell lines,
which allow us to perform investigations in a largely unlimited
and standardized manner. In this respect, Takigawa and
colleagues established one of the ﬁrst chondrocytic cell lines
from a human well-differentiated chondrosarcoma5. The
HCS-2/8 cells were described in several studies as retaining
a chondrocytic morphology in long-term culture. These cells
have since then been used in many studies in order to
investigate cellular reaction pattern of chondrocytic cells with
regard to loading6, analysis of intracellular signal trans-
duction pathways7,8 and in particular effects of connective
tissue growth factor (CTGF)9e12 and TNFa13. Recently,
a rheumatoid-arthritis speciﬁc antigen was reported to be
expressed by HCS-2/8 cells14.
Because the HCS-2/8 cells are common tools in cartilage
research as described above, we investigated in this study4
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conditions (growing densities) by comprehensive mRNA-
expression proﬁling. We used Affymetrix high-density
oligonucleotide microarrays to accomplish the measure-
ment of w12,600 genes in parallel and to generate an in-
depth expression proﬁle of HCS-2/8 cells and compared
these to the proﬁles of other human chondrocyte cell lines
and of primary human adult articular chondrocytes. In
addition, we used online quantitative PCR to conﬁrm part of
these ﬁndings.
Material and methods
CULTURE OF HCS-2/8 CELLS
The human HCS-2/8 chondrosarcoma cell line (around
passage 50e55) was cultured in DMEM medium (PAA,
Austria) supplemented with 20% fetal bovine serum (Gibco
BRL, Germany) and with (real-time PCR) and without (array
analysis) 50 mg/ml ascorbate (Sigma, Germany) in humid-
iﬁed atmosphere 5% CO2 in air at 37(C as described
5.
Cells were seeded with densities of 1! 105/cm2 and grown
for 3 days to obtain sub-conﬂuent stage cultures, 2! 105/
cm2 and cultured for 7 days to obtain conﬂuent stage
cultures, and 6! 105/cm2 and grown for 10 days for over-
conﬂuent stage cultures. AG, SG and SW1353 chondro-
sarcoma cell lines were cultured as described15 and
harvested at conﬂuence. Immortalized C28I2 and C28a4
chondrocyte lines were cultured as described by Goldring
et al.16 and harvested just at the point when cells reached
conﬂuence.
ISOLATION AND CULTURE OF PRIMARY
HUMAN CHONDROCYTES
Normal human knee articular cartilage were obtained
from two donors at autopsy (59 years male; 71 years male),
within 48 h of death. Cartilage pieces were ﬁnely chopped
and chondrocytes were enzymatically isolated as described
previously17. Chondrocytes were cultured in alginate beads
as described previously18. Cultures were maintained for
48 h in serum-free DMEM/F12 medium (Gibco BRL,
Germany) supplemented with 1% penicillin/streptomycin
solution (Gibco BRL, Germany) and 50 mg/ml ascorbate
(Sigma, Germany) and 10% fetal calf serum (Biochrom,
Germany). After 2 days the cells were washed in sterile
PBS, lysed in 350 ml lysis buffer/106 cells (Qiagen GmbH,
Germany) and stored at 80(C.
RNA ISOLATION
At the end of the culture period, cells were washed in
DEPC-PBS and lysed in Qiagen RNA lysis buffer (350 ml/
106 cells). RNA was isolated according to the manufactur-
er’s protocol (Qiagen Mini RNeasy total RNA isolation kit;
Qiagen GmbH, Germany). The quality of the isolated RNA
was assessed by ethidium bromide staining on agarose
gels and the concentration was determined by comparison
to an RNA standard of the known concentration (Peqlab
RNA marker, Peqlab Erlangen, Germany). Additionally,
spectral measurements (260/280 nm) were performed.
REVERSE TRANSCRIPTION
First strand cDNA was synthesized using 1 mg of total
RNA, 400 U M-MLV Reverse Transcriptase, RNase HMinus (Promega, Germany), 2 mM dNTPs (Roth) and
200 ng random primers (Promega, Germany) in a total
volume of 40 ml.
TAQMAN-PCR
TAQMAN-PCR was used to detect human COL2,
COL10, aggrecan, MMP-1, -3, -13 as well as ADAMTS-1,
-4 and -5, beta-actin and GAPDH. The primers (MWG
Biotech, Germany) and TAQMAN probes (Eurogentec,
Belgium) were designed using PRIMER EXPRESS
software (Perkin Elmer)17,19. In order to be able to obtain
quantiﬁable results for all genes speciﬁc standard curves
using sequence speciﬁc control probes were performed in
parallel to the analyses. Thus, for each gene a gene-
speciﬁc cDNA fragment was ampliﬁed by the gene-speciﬁc
primers (Table I) and cloned into pGEM T Easy (Promega,
Mannheim, Germany) or pCRII TOPO (Invitrogen, Karls-
ruhe, Germany). The cloned ampliﬁcation product was
sequenced for conﬁrmation of correct cloning. Cloned
standard probes were ampliﬁed using the QIAﬁlter Midi
Plasmid Kit (Qiagen, Germany) and linearized by restriction
digest. Linearized standard probes were gel puriﬁed using
the QIAquick Gel Extraction Kit (Qiagen). Puriﬁed probes
(fragments) were quantiﬁed using a ﬂuorometric assay
(Picogreen, Molecular Probes, Oregon, USA). Concentra-
tions were conﬁrmed (checked) by measuring the absor-
bance at 260 nm in an UV-spectrophotometer and
compared with DNA bands of known concentration
(MassRuler DNA Ladder, MBI Fermentas, Germany) in
an ethidium bromide stained agarose gel.
For the standard curves concentrations of 10, 100, 1000,
10,000, 100,000, as well as 1,000,000 molecules per assay
were used (all in triplicates).
A separate master-mix was made up for each of the
primer pairs and contained a ﬁnal concentration of 200 mM
NTPs, 600 nM Roxbuffer and 100 nM TAQMAN probe. For
all genes the ﬁnal reaction mix contained besides cDNA
and 1 U polymerase (Eurogentec, Belgium) forward and
reverse primers, the corresponding probes, and MgCl2 at
concentrations given in Table I. All experiments were
performed in triplicates.
GENECHIP EXPERIMENTS
8e10 mg of total RNA were reverse transcribed with T7-
(dT)24 primers (Qiagen) and 400 U SuperScript II RT
(Invitrogen Lifetechnologies, Germany) at 42(C. Second
strand synthesis was done with Escherichia coli DNA
polymerase I, E. coli DNA ligase and E. coli RNAse H at
16(C, cDNA fragments were blunt-ended with T4 DNA
polymerase. The cDNA was puriﬁed by phenolechloroform
extraction, precipitated with ethanol and resuspended in
12 ml RNAse-free water. Six microliters of the cDNA was
subjected to an in vitro transcription reaction using a Bioarray
high yield RNA transcript labeling kit (Enzo Diagnostics).
The cRNA was puriﬁed using RNeasy spin columns
(Qiagen) and fragmented by metal induced hydrolysis for
35 min at 94(C. Fifteen micrograms of fragmented cRNA
was hybridized together with control transcripts to the U95A
or U95Av2 GeneChips (Affymetrix, USA). Washing and
staining of the GeneChips were done according to the
instructions of the manufacturer using the Affymetrix Fluidics
station and chips were scanned with a confocal scanner
(HewlettePackard Gene array scanner). All procedures are
described in detail in the Affymetrix Technical Manual.
Table I
Sequences and concentrations of primers and probes as well as magnesium conditions for quantitative online-PCR experiments
Accession No. Primer nM Probe Mg
mM
GAPDH NM_002046 fw: GAAGGTGAAGGTCGGAGTC 50 CAAGCTTCCCGTTCTCAGCC 5.5
rv: GAAGATGGTGATGGGATTTC 900
Aggrecan NM_013227 fw:ACTTCCGCTGGTCAGATGGA 50 CCATGCAATTTGAGAACTGGCGCC 6
rv: TCTCGTGCCAGATCATCACC 50
COL2A1 NM_001844 fw:CAACACTGCCAACGTCCAGAT 50 ACCTTCCTACGCCTGCTGTCCACG 5.5
rv: CTGCTTCGTCCAGATAGGCAAT 300
COL1A1 NM_000088 fw: AGGGCCAAGACGAAGACATC 50 AATCACCTGCGTACAGAACGGCCTCA 6.5
rv: AGATCACGTCATCGCACAACA 300
MMP-1 NM_002421 fw: CTGTTCAGGGACAGAATGTGCT 300 ACGGATACCCCAAGGACATCTACAGCTCC 6.5
rv: TCGATATGCTTCACAGTTCTAGGG 900
MMP-3 NM_002422 fw: TTTTGGCCATCTCTTCCTTCA 900 AACTTCATATGCGGCATCCACGCC 4
rv: TGTGGATGCCTCTTGGGTATC 50
MMP-13 NM_002427 fw: TCCTCTTCTTGAGCTGGACTCATT 900 TCCTCAGACAAATCATCTTCATCACCACCAC 7
rv: CGCTCTGCAAACTGGAGGTC 50
ADAMTS-1 NM_006988 fw: GCCAAAGGCATTGGCTACTTC 900 CGTTTTGCAGCCCAAGGTTGTAGATGGT 7
rv: GTGGAATCTGGGCTACATGGA 900
ADAMTS-4 AF148213 fw: TGCCCGCTTCATCACTGA 900 ACAGTGCCCATAGCCATTGTCCAGGA 6
rv: CAATGGAGCCTCTGGTTTGTC 50
ADAMTS-5 AF142099 fw: CGCTGCCACCACACTCAA 300 AAGTGGCAGCACCAACACAACCAGC 4.5
rv: CGTAGTGCTCCTCATGGTCATCT 900
Ki-67 NM_002417 fw: CAGTGATCAACGCCGTAGGTC 900 CTTCCAGCAGCAAATCTCAGACAGAGGTTC 6
rv: TCGGCTGATAGACACTCTCTTTTG 900
Sox9 Z46629 fw: ACACACAGCTCACTCGACCTTG 900 TTAGGATCATCTCGGCCATCGTCGC 7
rv: GGAATTCTGGTTGGTCCTCTCTT 50
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The performance of the chip experiments was controlled
by the Affymetrix Microarray Suite (Version 4.0.1) software.
Raw data were then imported into the Rosetta Resolver
software (version 3.1, Rosetta Biosoftware) and analyzed
further using the provided functionality. Replicate experi-
ments were ﬁrst correlated to each other and then
combined to obtain more robust statistical values (detection
P-values). The detection P-values are an estimation to
assess whether a gene is detected as expressed compared
to background noise. The algorithm therefore compares the
intensity distribution of the signal with the intensity
distribution of negative control signals20. As a result to
each gene a signiﬁcance value is assigned, which indicates
the probability that a detected gene is expressed.
Results
GENECHIP AND QPCR BASED CHARACTERIZATION OF
HCS-2/8dINFLUENCE OF CULTURE DENSITYdGENERAL
GENE EXPRESSION ANALYSIS
For gene expression proﬁling of HCS-2/8 and primary
chondrocytes we used the Affymetrix GeneChip U95Av2
containing 12,625 probe sets. The whole list of expression
values from the proﬁling experiments are available online as
supplementary material. The 20 most abundant transcripts
from each HCS-2/8 culture conditions are listed in Table II,
many of them belonging to the basic cellular machinery of
the cells (i.e., ribosomal proteins etc.).
In vitro culture conditions such as the cell density in
monolayer cultures lead to a different morphological
phenotype of HCS-2/8 cells, but the corresponding molec-
ular changes are only partially revealed21. We therefore
performed in parallel two independent cultures of HCS-2/8
cells and gained expression proﬁles from cells in sub-
conﬂuent, conﬂuent, and over-conﬂuent stages. As shown
in Table III, w2700e5700 genes were detected in eachculture condition using a threshold detection P-value below
0.05. The proﬁles derived from the same culture density
showed always a very signiﬁcantly higher correlation than
proﬁles obtained from different culture densities [Table III
and Fig. 1(a)] indicating reproducible differences in gene
expression levels between these conditions. This was
further supported by hierarchical cluster analysis of all six
proﬁles. As shown in the dendrogram [Fig. 1(b)] the
replicates from the same culture condition clustered
together and, thus, were most similar to each other.
Next, we identiﬁed differentially expressed genes based
on an at least twofold difference in intensity and a corre-
sponding P-value of less than 0.001 as a threshold. Under
these conditions 608 genes and 1577 genes were
signiﬁcantly different when conﬂuent and over-conﬂuent
HCS-2/8 cells were compared to the sub-conﬂuent ones,
respectively. Among these genes, especially among the
most strongly repressed genes in conﬂuent and over-
conﬂuent stages, a high percentage were cell cycle control
genes, an excerpt of these is listed in Table IV and
discussed below. This was expected since the cells
proliferate at a much decreased rate when they reach
conﬂuence21.
GENE EXPRESSION PROFILING OF HCS-2/8 CELLSd
COMPARISON TO ISOLATED NORMAL ADULT ARTICULAR
CHONDROCYTESdANALYSIS OF MARKER GENES OF
CHONDROCYTIC DIFFERENTIATION
As a next step, we were interested in comparing the
levels of mRNA expression of HCS-2/8 cells with isolated
primary human adult articular chondrocytes. This revealed
not only important similarities in mRNA levels in between
the HCS-2/8 cells and freshly isolated adult human articular
chondrocytes, but also remarkable differences (Table V).
Steady state levels of aggrecan transcripts were consider-
able in sub-conﬂuent cells, increased in conﬂuent HCS-2/8
and remained high also in the over-conﬂuent stage.
Table II
Table showing the 20 most strongly detected genes in HCS-2/8 cells in the culture conditions tested: sub-confluent, confluent and over-confluent (aec) and in primary human chondrocytes
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Sub-conﬂuent Accession
No.
Intensity Conﬂuent Accession
No.
Intensity Over-conﬂuent Accession
No.
Intens
Ribosomal
protein L28
U14969 21,038 Clusterin M25915 29,463 Annexin A2 D00017 26,77
Clusterin M25915 20,484 Annexin A2
pseudogene 3
M62895 28,512 Clusterin M25915 24,98
Annexin A2
pseudogene 3
M62895 20,337 GAPDH U34995 27,855 Coupling
protein G(s)
alpha-subunit
(alpha-S1)
X04409 20,03
Laminin receptor 1 M14199 18,877 Ferritin H J04755 22,534 Ribosomal
protein L28
U14969 19,68
Ribosomal protein S5 U14970 18,505 Ribosomal
protein L28
U14969 22,381 Ribosomal
protein L8
Z28407 19,18
GAPDH U34995 17,939 Ribosomal
protein L8
Z28407 20,833 Ubiquitin C AB009010 19,17
Ribosomal protein S20 L06498 17,801 Biglycan J04599 20,806 Ribosomal
protein L37a
L06499 18,86
Ribosomal protein L8 Z28407 17,577 Elongation
factor 1 alpha
J04617 20,436 Ferritin H J04755 18,55
Gamma actin X04098 17,452 Ribosomal
protein L37a
L06499 20,243 Ribosomal
protein S2
X17206 18,06
Cyclophilin X52851 17,307 Ribosomal
protein L41
Z12962 20,210 GAPDH U34995 17,97
Pyruvate kinase M26252 16,957 Ribosomal
protein S5
U14970 20,205 Ribosomal
protein S20
L06498 17,95
Ribosomal protein S2 X17206 16,843 Ribosomal
protein S2
X17206 20,097 Ribosomal
protein L41
Z12962 17,93
Coupling protein G(s)
alpha-subunit (alpha-S1)
X04409 16,643 Ribosomal
protein S20
L06498 19,764 Ribosomal
protein S5
U14970 17,52
Ornithine decarboxylase
antizyme
D78361 16,333 Ubiquitin C AB009010 19,104 Biglycan J04599 17,09
Elongation factor
1 alpha
J04617 16,235 Coupling protein
G(s) alpha-subunit
(alpha-S1)
X04409 18,696 Ornithine
decarboxylase
antizyme
D78361 16,85
Ribosomal protein S11 X06617 16,135 Prolyl 4-hydroxylase
beta-subunit
M22806 18,583 Ribosomal
phosphoprotein P1
M17886 16,69
Ferritin light
polypeptide like 1 (FTL)
AL031670 16,102 Ribosomal
phosphoprotein P1
M17886 18,512 Elongation factor
1 alpha
J04617 15,65
Ferritin H J04755 16,101 Laminin receptor 1 M14199 18,484 Ribosomal
protein S17
M13932 15,33
Ribosomal
phosphoprotein P1
M17886 15,989 Ribosomal
protein L13a
X56932 18,466 junD X56681 14,79
RHO A proto-oncogene L09159 15,945 Serpine E2
(plasminogen
activator inhibitor
type 1)
AI743134 17,884 Ribosomal
protein L13a
X56932 14,69
928 J. Saas et al.: Expression proﬁling of HCS-2/8Collagen type II expression was found only at a very low
level with a slight increase in the conﬂuent and over-
conﬂuent cultures. Thus, whereas levels of aggrecan
expression in HCS-2/8 cells were close to primary cells,
much less collagen type II was expressed in HCS-2/8 cells
compared to isolated primary chondrocytes. Both results
were conﬁrmed by quantitative PCR [Table V(b)]. Other
typical gene products of articular chondrocytes such as
Table III
Correlation of GeneChip profiles. Replicates for primary human articular chondrocytes (PHC) (two donors) and biological replicates of HCS-2/
8 cells (duplicate cultures for each stage) for three culture conditions (_c: confluent; _s: sub-confluent; _o: over-confluent) were correlated to
each other. The number of genes (N ) called absent or present in the different array profiles according to the statistical analysis software are
given based on a statistical detection threshold of P! 0.05
PHC (T258) PHC (T259) HCS_s1 HCS_s2 HCS_c1 HCS_c2 HCS_o1 HCS_o2
N present 3234 2737 5667 5041 4631 4216 4600 4344
N absent 9391 9888 6958 7584 7994 8409 8025 8281
Correlation coefﬁcient (R) 0.989 0.992 0.992 0.993
Fig. 1. Correlation of different HCS-2/8 culture conditions: (A) Intensity diagrams of proﬁles derived from sub-conﬂuent (HCS-2/8_s), conﬂuent
(HCS-2/8_c), and over-conﬂuent (HCS-2/8_o) HCS-2/8 culture conditions. Each diagram shows a comparison of two proﬁles; a gene is
represented by a square and plotted according to it’s intensity value in the ﬁrst and second proﬁles. The intensity range is from 0 to 40,000 (rel.
units) on both axes. The correlation value R for the gene intensities has been calculated for each comparison of two proﬁles. The comparisons
of two proﬁles from the same culture conditions (interexperimental variability) show a higher correlation (upper row) than proﬁles derived from
different HCS-2/8 culture stages (lower row). (B) Hierarchical clustering of HCS-2/8 proﬁles derived from the different culture conditions. An
agglomerative clustering algorithm with Euclidean distance as a metric was chosen. In order to combine groups complete linkage was
selected. Given are correlation values for paired groups.
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Cell cycle related genes with significant regulation in HCS-2/8 cells in dependence to the culture density. (R c/s: ratio confluent vs sub-
confluent; R o/s over-confluent vs sub-confluent)
Affymetrix
qualiﬁer
Sequence description Accession No. Ratio c/s P-value Ratio o/s P-value
1911_s_at Growth arrest and
DNA-damage-inducible
protein (GADD45)
M60974 2.4 2.86E03 9.3 !1.0E30
37028_at Growth arrest and
DNA-damage-inducible
protein (GADD34)
U83981 2.6 8.47E04 7.9 !1.0E30
635_s_at Protein phosphatase 2A
regulatory subunit B56-beta
L42374 1.9 0.06 6.8 2.55E08
2031_s_at Cyclin-dependent kinase
inhibitor 1A (p21, Cip1)
U03106 2.1 !1.0E30 4.5 !1.0E30
40235_at Activated p21cdc42Hs
kinase (ack)
L13738 1.7 0.01 4.2 2.04E13
36634_at btg2 U72649 1.9 6.75E04 3.7 !1.0E30
1860_at bcl2 U58334 1.6 0.39 3.4 1.00E11
36650_at CyclinD2 D13639 2.4 2.05E03 3.1 2.71E05
38326_at G0S2 M69199 2.3 0.13 2.8 5.11E03
37294_at btg1 X61123 1.9 2.24E14 2.6 3.02E26
1924_at Cyclin H U11791 1.3 0.05 2.5 6.18E21
1824_s_at Proliferating cell
nuclear antigen (PCNA)
J05614 0.35 5.32E05 0.27 8.68E25
1536_at cdc6-Related protein U77949 0.17 1.51E06 0.14 3.42E05
1925_at Cyclin F Z36714 0.13 4.78E03 0.13 1.55E04
35249_at Cyclin E2 AF091433 0.14 5.38E26 0.13 5.93E30
1599_at Cyclin-dependent kinase
inhibitor 3 (CDK2-associated
dual speciﬁcity phosphatase)
L25876 0.12 !1.0E30 0.13 !1.0E30
40041_at Retinoblastoma-associated
protein HEC
AF017790 0.13 2.60E16 0.11 2.13E14
1803_at cdc2 (cell division cycle 2. G1
to S and G2 to M)
X05360 0.17 5.83E23 0.10 !1.0E30
1721_g_at mad2 (mitotic arrest deﬁcient
yeast homolog-like 1)
U65410 0.15 2.17E09 0.10 !1.0E30
40549_at cdk5 L04658 0.34 2.77E07 0.10 6.87E21
34852_g_at Serine/threonine kinase 6 AF011468 0.19 !1.0E30 0.08 1.02E30
418_at Ki-67 X65550 0.26 !1.0E30 0.08 !1.0E30
37458_at cdc45-related protein AJ223728 0.11 4.85E23 0.08 !1.0E30
1178_at Dihydrofolate reductase NM_000791 0.15 6.70E13 0.06 !1.0E30
32263_at Cyclin B2 AL080146 0.05 !1.0E30 0.05 2.67E30
40145_at DNA topoisomerase II AI375913 0.12 !1.0E30 0.04 !1.0E30
1945_at Cyclin B1 M25753 0.10 !1.0E30 0.03 !1.0E30
38414_at cdc20 (cell division cycle
20 S. cerevisiae homolog)
U05340 0.10 !1.0E30 0.03 !1.0E30
910_at Thymidine kinase M15205 0.10 !1.0E30 0.02 !1.0E30collagen types VI, IX, XI, and XVI as well as proteoglycan
link protein and small proteoglycans (biglycan, ﬁbromodu-
lin) were also strongly expressed by HCS-2/8 cells similar to
primary human articular chondrocytes. Expression of
collagen type X, a marker of hypertrophic chondrocytes,
was very low in any culture condition and only slightly
increased with increasing culture density (Table V). Thus,
overall only a very limited shift in the phenotype towards
chondrocyte hypertrophy of the HCS-2/8 cells was ob-
served in the different culture conditions. Also, long-term
high-density cultures did not reveal signiﬁcant alterations in
collagen type X expression (own unpublished results).
Of note, also other marker genes typical for chondrocytes
were expressed: thus, signiﬁcant levels of CDRAP and
SOX9 were detected. Steady state levels of SOX9 tran-
scripts were signiﬁcant in sub-conﬂuent cells, increased in
conﬂuent HCS-2/8 and were high also in the over-conﬂuent
stage, similar to the SOX9 in primary human articular
chondrocytes. SOX9 is known to be crucial for thechondrocytic phenotype in fetal22 and presumably also
adult chondrocytes23.
GENE EXPRESSION PROFILING OF HCS-2/8 CELLSdCOMPAR-
ISON TO ISOLATED NORMAL ADULT ARTICULAR CHONDRO-
CYTESdCATABOLIC GENES
A severe alteration in gene expression levels in between
the HCS-2/8 cells and physiological chondrocytes was
found with regard to cartilage matrix degrading enzymes.
MMP-1, -3, and -13 mRNAs were detectable, but under
most conditions only by qPCR due to their low expression
levels in HCS-2/8 in general. Thus, MMP-1, -3, and -13
mRNA levels were decreased at least by an order of
magnitude compared to physiological chondrocytes [Table
V(b)]. Among the cartilage matrix degrading ADAMTS
proteases (these were not represented on the U95Av2
GeneChips and were due to their high importance for
cartilage degradation additionally analyzed by quantitative
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Table listing a comparative analysis of mRNA-expression levels of typical gene products of articular chondrocytes in HCS-2/8 (_s: sub-
confluent; _c: confluent; _o: over-confluent) vs normal primary human chondrocytes (‘‘PHC’’) as detected by (a) oligochip array and (b) qPCR
analysis
(a) Oligochip array analysis
Gene Accession No. HCS-2/8_s (intensity) HCS-2/8_c (intensity) HCS-2/8_o (intensity) PHC (intensity)
Aggrecan M55172 6497 10,424 9750 15,186
COL1A1 Y15915 469 406 662 567
COL2A1 L10347 45 167 123 22,562
COL3A1 X14420 3085 2937 209 3685
COL6A1 X15880 4152 5212 3861 5279
COL6A2 X15882 3534 4702 4777 10,880
COL6A3 X52022 4041 4323 2774 6963
COL9A3 L41162 7491 13,487 11,463 2449
COL10A1 X60382 187 205 200 1344
MMP-1 M13509 56 86 15 13,122
MMP-2 M55593 245 336 211 687
MMP-3 X05232 361 64 26 27,047
MMP-13 X75308 102 38 23 5603
MMP-14 X83535 350 320 109 305
(b) qPCR analysis
Gene Accession No. HCS-2/8 (relative to GAPDH) PHC (relative to GAPDH) beads PHC (relative to GAPDH) monolayers
Aggrecan NM_013227 3.80 0.7 0.95
Col1A1 NM_000088 0.0014 0.011 0.114
Col2A1AB NM_001844 0.0009 1.012 3.3
Col2A1A L10347 0.0002 0.143 0.229
Col10A1 NM_000493 0.0003 0.036 0.014
ADAMTS-1 NM_006988 0.050 0.130 0.134
ADAMTS-4 AF148213 0.0007 0.0009 0.001
ADAMTS-5 AF142099 0.002 0.295 0.069
MMP-1 NM_002421 0.018 1.20 0.37
MMP-3 NM_002422 0.017 62.9 37
MMP-13 NM_002427 0.007 0.955 0.121
SOX9 Z46629 0.11 0.18 0.09PCR), ADAMTS-1 was most abundant with highest
expression in the sub-conﬂuent stage, ADAMTS-4 and -5
were very low (!0.005/GAPDH) in all culture conditions
(Table VI). Altogether, ADAMTS-1 and -4 were expressed
by the HCS-2/8 cells in the same order of magnitude than
by physiological chondrocytes.
GENE EXPRESSION PROFILING OF HCS-2/8 CELLSdCELL
CYCLE CONTROL GENES
Proliferating activity of HCS-2/8 cells was markedly
reduced when the cells reached conﬂuence and sub-
sequently became over-conﬂuent (21, data not shown). This
is reﬂected by the strongly increased expression of
GADD45 and GADD34 (Table IV), known to be up-
regulated in growth-arrested cells. Increased expression
of several other genes was also detected like the regulatory
subunit B56, the Ser/Thr protein phosphatase subunit 2a or
the GO/G1 switch gene (G0S2), which are associated
with growth and differentiation processes24,25. Also, thewell-characterized inhibitor of a cyclin-dependent kinase
p21 was found and the antiproliferative proteins BTG1 and
BTG2. On the other hand, several cell cycle promoting
genes were down-regulated in conﬂuent and over-conﬂuent
stages (Table IV). Among these were several kinases
(cdc2, cdk5), major cyclins of eukaryotes (cyclin B1, B2,
cyclin E, cyclin F) as well as enzymes of DNA replication
(dihydrofolate reductase and topoisomerase II). Also pro-
liferation-associated genes PCNA and Ki-67 were clearly
down-regulated as shown by cDNA array analysis as well
as quantitative PCR (Tables IV and VI; Fig. 2).
GENE EXPRESSION PROFILING OF HCS-2/8 CELLSd
COMPARISON OF THE DIFFERENT CULTURE CONDITIONS
WITH RESPECT TO THE CHONDROCYTIC PHENOTYPE
Hierarchical clustering based on the expression of a large
number of (signiﬁcantly detected [P-value!0.05]) genes of
the proﬁles from cultured primary articular human chon-
drocytes derived from two individuals and from the proﬁlesTable VI
Table presenting the expression values of a subset of anabolic and catabolic marker genes of cartilage matrix turnover as well as proliferation-
associated antigen Ki-67 and chondrogenic differentiation factor SOX9 in HCS-2/8 cells in sub-confluent, confluent and over-confluent culture
conditions using quantitative PCR analysis (shown are always the average values/GAPDH of three replicates of two independent cultures and
measurements)
Actin Aggrecan COL2 COL10 ADAMTS-1 ADAMTS-4 ADAMTS-5 MMP-1 MMP-3 MMP-13 Ki-67 SOX9
Sub-conﬂuent 7.5 1.4 0.0002 0.0002 0.12 0.0011 !0.0001 0.007 0.034 0.008 0.016 0.05
Conﬂuent 5.3 3.8 0.0009 0.0003 0.05 0.0007 0.002 0.018 0.017 0.007 0.004 0.11
Over-conﬂuent 5.0 11.3 0.0008 0.0004 0.06 0.0002 0.003 0.005 0.016 0.004 0.006 0.31
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Fig. 2. Correlation of the expression of proliferation-associated antigens Ki-67 (A: cDNA array analysis, B: qPCR) and PCNA (A: cDNA array
analysis) in HCS-2/8 cells in the different culture conditions (given are arbitrary values adapted to the maximal value as 1 (s: sub-conﬂuent, c:
conﬂuent, o: over-conﬂuent). Given are arbitrary units with sub-conﬂuent culture levels set to 100 (%).of the HCS-2/8 cells cultured in the different culture
conditions provided a clear separation of the primary
chondrocytes from the HCS-2/8 proﬁles, but did not resolve
the relatedness of the culture stages to the primary cells
(data not shown). Therefore, we made a selection of those
genes, which discriminated the three HCS-2/8 stages by
performing an ANOVA-test treating sub-conﬂuent, conﬂuent
and over-conﬂuent proﬁles as three separate groups. The
proﬁles were then clustered using the 587 most signiﬁcant
genes (according to a cut-off value of P! 109) and
principal component analysis as clustering algorithm. The
largest variance of the data set (principal component 1) is
attributed to the different HCS stages and the second
largest variance (principal component 2) is identiﬁed for
PHC and the sub-conﬂuent HCS-2/8 cells. In the coordinate
system of the ﬁrst two principal components (Fig. 3) the
conﬂuent culture of HCS-2/8 is most closely related to the
primary chondrocytes used in this study (Fig. 3).
COMPARISON OF CHONDROCYTIC CELL LINES AND PRIMARY
HUMAN CHONDROCYTES
Finally, we have cultured several other human chondro-
cyte cell lines as monolayers and isolated RNA for the
generation of GeneChip proﬁles. C28I2 and C28a4 are
SV40 T-antigen transformed chondrocytes26 and AG, SG15
and SW1353 are chondrosarcoma derived cell lines similar
to the HCS-2/8 cells. Hierarchical clustering of all proﬁles
showed that HCS-2/8 cells are most closely related to the
primary chondrocytes from all cell lines studied (Fig. 4). This
is clearly the case for molecules such as aggrecan, which
are expressed in HCS-2/8 cells at a much higher level than
in the other cell lines and in a level comparable to
physiological chondrocytes. In contrast, none of the cell
lines investigated expressed signiﬁcant amounts of colla-
gen type II mRNA. However, this is clearly a general view
and in different aspects different cell lines might reﬂect best
the physiological situation: thus, HCS-2/8 cells are re-
sponsive to BMP-7, but not to Il-1b (own unpublished data),
whereas Goldring and colleagues were able to report an Il-
1b response in the C28/I2 and T/C28a4 cell lines16,26.
Discussion
Most importantly, our study shows how careful one needs
to be in choosing in vitro model systems, particularly long-
term cell lines, in order to obtain a suitable system forHCS-2/8_s_1
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Fig. 3. Visualization of gene expression proﬁles from three HCS-2/8
culture stages and primary human chondrocytes after principal
component analysis. Duplicate proﬁles of HCS-2/8 in sub-conﬂuent
[s], conﬂuent [c] and over-conﬂuent [o] stages and two proﬁles from
primary human chondrocytes (samples T258, T259) were subject
to a principal component analysis. The ﬁrst principal component
accounts for the highest variance in the data set and the
succeeding principal components account for as much of the
remaining variance as possible. The proﬁles (squares) are then
shown in the space of the ﬁrst two principal components (x- and y-
axes, respectively) in order to infer the relatedness of the proﬁles.
The ﬁrst principal component (PC1) indicates the difference in
between the various stages of the HCS-2/8 cell line. It clearly
separates the most distant stages, sub-conﬂuent and over-
conﬂuent, and places the conﬂuent stage between the other two.
Within the ﬁrst principal component the primary chondrocytes are
located nearly in between the sub-conﬂuent and conﬂuent stages of
HCS-2/8, with a slight orientation towards the conﬂuent stage. The
second principal component represents the difference between the
primary chondrocytes and the sub-conﬂuent stage of HCS-2/8
cells. This component clearly indicates that the proﬁles of conﬂuent
and over-conﬂuent stages of the HCS-2/8 cell line are closer to the
primary chondrocytes than the sub-conﬂuent stage. The difference
is even clearer as soon as the ﬁrst two principal components are
taken into account. The two-dimensional plot indicates that the
primary chondrocytes are more similar to the conﬂuent stage of
HCS-2/8 than to the sub- and over-conﬂuent stages of the HCS-2/8
cells.
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Fig. 4. Cluster analysis of different human chondrocyte cell lines (HCS-2/8, C28a2, C28A4, C28I2, SW1353, AG, SG) and primary human
chondrocytes (two donors). All samples were cultured as high-density monolayer cultures and duplicate proﬁles were generated. An
agglomerative clustering algorithm with Euclidean distance as a metric was chosen. In order to combine groups complete linkage was
selected. The correlation values calculated by the Resolver software are given for each paired group.investigating effects of interest. Our study highlights central
issues related to the use of chondrocyte cell lines in
cartilage research as a substitute for primary articular
chondrocytes. The major issue of cell lines appears to be
that they mainly proliferate: thus, they show mainly the
expression of house-keeping genes involved in the basic
cell machinery (e.g., ribosomal genes) as well as rather
increased levels of cell cycle-associated proteins and show
less expression of genes of matrix synthesis and turn-
over18. In fact, proliferative activity appears to be negatively
correlated to the matrix-producing chondrocytic phenotype
at least in the adult. Our study also clearly shows that
reduced proliferation of HCS-2/8 is linked to the expression
of the chondrocyte phenotype; thus, aggrecan or SOX9 are
induced in this condition. This is similar to physiological
chondrocytes, which show in most instances a decreased
expression of cartilage matrix components in areas of
chondrocyte proliferation in osteoarthritic cartilage degen-
eration27 and reﬂected in many neoplasms including
chondrosarcomas, which cease largely cartilage matrix
formation as soon as they increase proliferative activity28.
Also, chondrocytes cultured under proliferative conditions
loose their phenotype and, thus, cartilage-speciﬁc matrix
synthesis3. Altogether, the very low expression of most
matrix degrading proteases is consistent with the very low
expression of extracellular matrix genes and most likely
reﬂects, as discussed above, the very much reduced
priority in proliferating cells for synthesizing, depositing
and degrading extracellular matrix.
Clearly, HCS-2/8 cells are a suitable in vitro model for
studying aggrecan gene expression: they express it at
levels similar to many adult chondrocytes and do react, e.g.,
to anabolic factors such as BMP-7 (own unpublished
results), but they are hardly able to reﬂect collagen type II
expression. The same is true if one is interested in
investigating the regulation and activity of classical cartilage
matrix degrading enzymes. Major subtypes of proteases
expressed by physiological chondrocytes in vivo and in
vitro17 such as MMP-3 and the collagenases MMP-1 and
MMP-13 are hardly expressed by the cells. On the other
hand, in articular chondrocytes after isolation in vitro change
their gene expression proﬁle in vitro signiﬁcantly. They very
much increase expression of MMP-1 and MMP-1317. Thus,
in this respect, HCS-2/8 cells might to some extent even
better reﬂect the in vivo situation as isolated chondrocytes.Altogether HCS-2/8 cells only in part reﬂect the in vivo
(and in vitro) situation of articular chondrocytes in situ,
though this cell line appears to be closer in many respects
to physiological chondrocytes than the other chondrocytic
cell lines tested in this investigation. Clustering analysis
identiﬁed that the ‘‘best’’ (i.e., the most physiological)
molecular phenotype is achieved if HCS-2/8 cells are kept
in conﬂuent culture conditions.
Cell lines are of somewhat limited use as substitutes for
primary chondrocytes, but also primary chondrocytes in
vitro are not a good substitute for chondrocytes in vivo17.
They also show severe alterations in gene expression, in
particular also in the expression levels of anabolic and
catabolic genes (17; unpublished own observation). An
advantage of HCS-2/8 cells compared to physiological
chondrocytes is the rather high phenotypic stability of the
cells compared to primary chondrocytes, which tend to
loose quickly their speciﬁc expression properties after
isolation from articular cartilage. In particular after long-
term maintenance under culture conditions allowing the
propagation of the primary cells major shifts of the
expression pattern have been described3,4. Also the fact
that using cell lines allows to avoid the donor variability one
always takes into account in any experiment with primary
cells. Also, primary articular chondrocytes are hardly
available to the extent needed. Thus, in contrast to primary
articular chondrocytes, which hardly proliferate if main-
tained under phenotype stabilizing conditions, HCS-2/8
cells have the advantage that they can be propagated
theoretically to an unlimited extent. Overall, a successful
approach will have to select one of the available chon-
drocyte cell lines and to validate ﬁndings obtained using
primary chondrocytes or intact human articular cartilage.
This allows to establish a reproducible in vitro model, which
enables the use of large numbers of cells, and sub-
sequently to relate back to the physiologic situation. This
will enable a realistic use of the versatile tools and allow
a more reliable interpretation of the results obtained in such
studies.
Our data are in line with previous investigations showing,
e.g., a strong expression of CTGF29 as well as aggrecan5,8
in HCS-2/8 cells comparable to primary human articular
chondrocytes, but we could not conﬁrm other data such as
the expression of collagen type II mRNA by these cells as
reported previously5. This might be related to culture
933Osteoarthritis and Cartilage Vol. 12, No. 11conditions (e.g., other serum batches) or the fact that the
present experiments were performed using passage 50e55
cells while previous studies were performed with passage
20e40 cells (5; Takigawa, unpublished observations).
Therefore, whether this discrepancy is due to a shift of
the cellular phenotype during many passages or slightly
different culture conditions is unclear at the moment.
Clearly, this issue requires further investigations, but, as
conﬁrmed in this study, chondrocytic cells are very much
dependent on the exact culture conditions.
Another aspect not explicitly dealt with in this paper is
obviously the use of isolated chondrosarcoma derived cell
lines for investigating the nature and properties of cartilag-
inous neoplasms and their cells. However, no extensive
data on the expression pattern in these neoplasms are so
far available. Clearly, neoplastic chondrocytes except in
very highly differentiated lesions do also proliferate5 much
more strongly than adult articular chondrocytes. Interest-
ingly, neoplastic chondrocytes appear to express more
likely aggrecan and loose more often the capability of
expressing collagen type II5,30, a feature presumably
reﬂected by the expression pattern found in HCS-2/8 cells.
Clearly, the in-depth analysis of expression data of HCS-2/8
cells by cancer geneticians will open up new insights into
the biology of neoplastic chondrocytes, but this was not in
the range of this investigation.
This study paints a molecular portrait of a frequently used
chondrocyte cell line which will help to direct further studies in
the ﬁeld, not only by the data explicitly discussed in this paper,
but even more importantly through the full dataset available
online allowing the individual researcher to exploit the dataset
with a speciﬁc question inmind. Thus, our paper together with
others will allow a more speciﬁc use of this and other
chondrocytic cell lines for replacing physiological chondro-
cytes in amanner that does not implicate an intolerable loss of
the physiological context, but allows expanding our knowl-
edge about cartilage cell physiology and pathophysiology in
optimized and feasible in vitro systems.
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